• Policy
• New drug approval fee to rise next year
• by Lee, Hye-Kyung Dec 12, 2024 05:49am

• Company
• 'Lalaola' wins 2024 Pharma Industry ad grand prize
• by Son, Hyung Min Dec 11, 2024 05:54am

• Company
• Lilly will directly distribute Trulicity in Korea next year
• by Lee, Tak-Sun Dec 11, 2024 05:54am

• Company
• Jemperli expands indication to all endometrial cancers
• by Whang, byung-woo Dec 11, 2024 05:52am

• Company
• MM drug Revlimid continues to thrive after patent expiry
• by Eo, Yun-Ho Dec 11, 2024 05:52am

• Company
• Antibiotic clarithromycin market grows fourfold in 3 yrs
• by Chon, Seung-Hyun Dec 10, 2024 05:53am

• Company
• 1st MET-targeting anticancer drug likely to get reimb in KOR
• by Eo, Yun-Ho Dec 10, 2024 05:53am

• Company
• GC Biopharma&Dong-A ST research mRNA-LNP-based treatment
• by Kim, Jin-Gu Dec 10, 2024 05:52am

• Company
• ‘Pluvicto, a new standard therapy for prostate cancer?'
• by Whang, byung-woo Dec 10, 2024 05:52am

• Policy
• Cancellation policy for innovative pharmas certification
• by Kang, Shin-Kook Dec 9, 2024 05:47am